Univariate logistic regression | Multiple logistic regression | |||||
---|---|---|---|---|---|---|
Wald Χ2 | P | OR (95% CI) | Wald Χ2 | P | OR (95% CI) | |
Group, Rosuva/Eze vs. Rosuva | 11.0 | 0.001 | 5.60 (2.03-15.5) | 9.0 | 0.003 | 6.29 (1.89-20.91) |
Age, per year | 0.5 | 0.461 | 1.02 (0.97-1.06) | |||
Male gender, male vs. female | 3.3 | 0.068 | 0.42 (0.16-1.07) | |||
BMI, per kg/m2 | 0.008 | 0.930 | 1.00 (0.89-1.11) | |||
Systolic blood pressure, per mmHg | 0.002 | 0.964 | 1.00 (0.97-1.03) | |||
Diatolic blood pressure, per mmHg | 1.8 | 0.181 | 0.97 (0.92-1.02) | |||
Waist circumference, per cm | 0.07 | 0.790 | 1.01 (0.96-1.05) | |||
MetSyn, yes vs. no | 0.001 | 0.969 | 0.98 (0.37-2.63) | |||
Prevalence CVD, yes vs. no | 0.1 | 0.706 | 1.38 (0.26-7.33) | |||
Prevalence CI, yes vs. no | 3.3 | 0.069 | 4.73 (0.89-25.23) | |||
Hypertension, yes vs. no | 0.01 | 0.904 | 1.06 (0.40-2.84) | |||
Diabetes therapy | ||||||
Oral hypoglycemic agent, yes vs. no | 1.9 | 0.169 | 0.42 (0.12-1.45) | |||
sulfonylurea, yes vs. no | 0.05 | 0.815 | 1.12 (0.43-2.90) | |||
pioglitazone, yes vs. no | 0.1 | 0.758 | 0.86 (0.34-2.19) | |||
metformin, yes vs. no | 1.6 | 0.210 | 1.83 (0.71-4.69) | |||
α-glucosidase inhibitor, yes vs. no | 0.7 | 0.392 | 1.75 (0.48-6.36) | |||
dipeptidyl peptidase-4 inhibitor, yes vs. no | 0.000 | 0.991 | 1.01 (0.21-4.86) | |||
LDL-C, per mg/dL | 8.2 | 0.004 | 0.97 (0.94-0.99) | 10.6 | 0.001 | 0.95(0.92-0.98) |
sdLDL-C, per mg/dL | 4.5 | 0.034 | 0.95 (0.90-1.00) | |||
MDA-LDL, per U/L | 3.3 | 0.070 | 0.99 (0.97-1.00) | |||
HDL-C, per mg/dL | 3.5 | 0.061 | 0.96 (0.93-1.00) | |||
LDL/HDL ratio | 0.2 | 0.677 | 0.86 (0.43-1.74) | |||
TG, per mg/dL | 0.4 | 0.526 | 1.00 (0.99-1.00) | |||
RLP-C, per mg/dL | 0.2 | 0.637 | 0.96 (0.80-1.15) | |||
FPG, per mg/dL | 0.07 | 0.784 | 1.00 (1.00-1.02) | |||
Fasting serum insulin, per μU/mL | 0.009 | 0.926 | 1.00 (0.94-1.06) | |||
HOMA-IR | 0.004 | 0.949 | 1.00 (0.82-1.24) | |||
HOMA-B | 0.1 | 0.739 | 1.00 (0.99-1.00) | |||
HbA1c, per % | 0.3 | 0.559 | 1.2 (0.69-2.00) | |||
Aspartate aminotransferase, per U/L | 1.6 | 0.204 | 1.03 (0.98-1.08) | |||
Alanine aminotranserase, per U/L | 3.6 | 0.058 | 1.04 (1.00-1.07) | |||
Creatine kinase, per mg/dL | 1.03 | 0.311 | 1.00 (0.99-1.00) | |||
Creatine, per mg/dL | 2.8 | 0.096 | 5.7 (0.73-44.58) |